Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284211857> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2284211857 endingPage "700" @default.
- W2284211857 startingPage "699" @default.
- W2284211857 abstract "To the Editor: We congratulate Rodrigues et al ( 1 Rodrigues G. Oberije C. Senan S. et al. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non–small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys. 2015; 91: 133 Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar ) on their publication. The authors performed a multi-institutional retrospective analysis to explore whether intermediate dose escalation would lead to higher survival in stage III non-small cell lung cancer (NSCLC). They found a trend toward better survival in the intermediate dose group. Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non–Small-Cell Lung Cancer Beneficial? A Multi-Institutional Propensity Score Matched AnalysisInternational Journal of Radiation Oncology, Biology, PhysicsVol. 91Issue 1PreviewThe clinical benefits and risks of dose escalation (DE) for stage III non–small-cell lung cancer (NSCLC) remain uncertain despite the results from Radiation Therapy Oncology Group (RTOG) protocol 0617. There is significant heterogeneity of practice, with many clinicians prescribing intermediate dose levels between the 0617 study arms of 60 and 74 Gy. This study investigated whether this strategy is associated with any survival benefits/risks by analyzing a large multi-institutional database. Full-Text PDF In Reply to Cobben and JagerInternational Journal of Radiation Oncology, Biology, PhysicsVol. 92Issue 3PreviewTo the Editor: We thank Drs Cobben and Jager (1) for their interest in our analysis (2) examining the relationship between intermediate dose escalation and survival for stage III non-small cell lung cancer (NSCLC). The authors suggested that the time interval between positron emission tomography/computed tomography (PET/CT) and treatment may have influenced the survival results and have summarized the evidence linking PET/CT timing with disease progression. Full-Text PDF" @default.
- W2284211857 created "2016-06-24" @default.
- W2284211857 creator A5031913794 @default.
- W2284211857 creator A5045718947 @default.
- W2284211857 date "2015-07-01" @default.
- W2284211857 modified "2023-10-14" @default.
- W2284211857 title "In Regard to Rodrigues et al" @default.
- W2284211857 cites W1977155686 @default.
- W2284211857 cites W1988082108 @default.
- W2284211857 cites W2000009782 @default.
- W2284211857 cites W2022018366 @default.
- W2284211857 cites W2059149151 @default.
- W2284211857 cites W2071615683 @default.
- W2284211857 cites W2127264417 @default.
- W2284211857 cites W2164534935 @default.
- W2284211857 doi "https://doi.org/10.1016/j.ijrobp.2015.02.044" @default.
- W2284211857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26068496" @default.
- W2284211857 hasPublicationYear "2015" @default.
- W2284211857 type Work @default.
- W2284211857 sameAs 2284211857 @default.
- W2284211857 citedByCount "1" @default.
- W2284211857 countsByYear W22842118572015 @default.
- W2284211857 crossrefType "journal-article" @default.
- W2284211857 hasAuthorship W2284211857A5031913794 @default.
- W2284211857 hasAuthorship W2284211857A5045718947 @default.
- W2284211857 hasConcept C121608353 @default.
- W2284211857 hasConcept C126322002 @default.
- W2284211857 hasConcept C143998085 @default.
- W2284211857 hasConcept C146357865 @default.
- W2284211857 hasConcept C151730666 @default.
- W2284211857 hasConcept C17923572 @default.
- W2284211857 hasConcept C2776256026 @default.
- W2284211857 hasConcept C2776694085 @default.
- W2284211857 hasConcept C2992520072 @default.
- W2284211857 hasConcept C509974204 @default.
- W2284211857 hasConcept C71924100 @default.
- W2284211857 hasConcept C86803240 @default.
- W2284211857 hasConceptScore W2284211857C121608353 @default.
- W2284211857 hasConceptScore W2284211857C126322002 @default.
- W2284211857 hasConceptScore W2284211857C143998085 @default.
- W2284211857 hasConceptScore W2284211857C146357865 @default.
- W2284211857 hasConceptScore W2284211857C151730666 @default.
- W2284211857 hasConceptScore W2284211857C17923572 @default.
- W2284211857 hasConceptScore W2284211857C2776256026 @default.
- W2284211857 hasConceptScore W2284211857C2776694085 @default.
- W2284211857 hasConceptScore W2284211857C2992520072 @default.
- W2284211857 hasConceptScore W2284211857C509974204 @default.
- W2284211857 hasConceptScore W2284211857C71924100 @default.
- W2284211857 hasConceptScore W2284211857C86803240 @default.
- W2284211857 hasIssue "3" @default.
- W2284211857 hasLocation W22842118571 @default.
- W2284211857 hasLocation W22842118572 @default.
- W2284211857 hasOpenAccess W2284211857 @default.
- W2284211857 hasPrimaryLocation W22842118571 @default.
- W2284211857 hasRelatedWork W2277416945 @default.
- W2284211857 hasRelatedWork W2355670240 @default.
- W2284211857 hasRelatedWork W2357406576 @default.
- W2284211857 hasRelatedWork W2362144381 @default.
- W2284211857 hasRelatedWork W2376593068 @default.
- W2284211857 hasRelatedWork W2413020017 @default.
- W2284211857 hasRelatedWork W2418514417 @default.
- W2284211857 hasRelatedWork W2899939825 @default.
- W2284211857 hasRelatedWork W4291189777 @default.
- W2284211857 hasRelatedWork W1899415052 @default.
- W2284211857 hasVolume "92" @default.
- W2284211857 isParatext "false" @default.
- W2284211857 isRetracted "false" @default.
- W2284211857 magId "2284211857" @default.
- W2284211857 workType "article" @default.